• No results found

Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study"

Copied!
10
0
0

Loading.... (view fulltext now)

Download now ( 10 Page )

Full text

Loading

Figure

Table 1 Descriptive data of 1011 patients with early RA at baseline and after 24 months of disease
Table 2 Frequency of citrullinated/mutated antibodies in 1011 patients at baseline, with OR and 95% CIs calculated on controls (n=477) analysed at the laboratory and stratified for antibodies against cyclic citrullinated peptide (anti-CCP2)
Table 3 Simple and multivariable linear regression with DAS28-AUC at 24 months as dependent variable and ACPA reactivities and treatment as covariates presented with significant results
Figure 1 Development of DAS28 during the first 24 months of the RA disease stratified into two trajectories (n=617, n=394, respectively), adjusted for sex and age
+2

References

Download now ( PDF - 10 Page - 518.38 KB )

Related documents

Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases

When comparing the findings of the present study with previous results, there is a difference in the percentage of triple positivity for anti- CarP, ACPA and RF: indeed, the

Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking

3 Three-year disease course of early rheumatoid arthritis in relation to secretory immunoglobulin A (SIgA) anti-cyclic citrullinated peptide (anti-CCP) antibody status as mirrored by

Serum levels of 14 3 3η protein supplement C reactive protein and rheumatoid arthritis associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent onset inflammatory polyarthritis

anti-Sa: antibodies to Sa/citrullinated vimentin; AUC: area under the curve; CHUS: Centre hospitalier universitaire de Sherbrooke; BMI: body mass index; CI: confidence interval;

Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study

The association of survivin status with joint damage (total Sharp-van der Heijde score), disease activity (Disease Activity Score based on evaluation of 28 joints (DAS28)),

Presence and utility of IgA class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project

Correlation between IgG-class antibodies against cyclic citrullinated peptides (IgG anti-CCP) levels and IgA-class anti- bodies against cyclic citrullinated peptides (IgA

The likelihood of persistent arthritis increases with the level of anti citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis

This study of persistent arthritis in patients with arthritis of less than 16 weeks' duration demonstrates that high positive levels of IgM RF and anti-CCP, as compared